GSK and Alector ink neurodegenerative diseases partnership
Under the terms of the collaboration, Alector could receive up to $1.5bn in milestone payments
Read More
Tag: Alector
- European life sciences coalition launched to boost investment ecosystem
- 99mtc‑maraciclatide granted fast track status for ILD imaging
- Bioxytran reports rapid viral clearance in phase 2 trial
- Thx Pharma and Biocodex sign rare disease licensing deal
- AstraZeneca bladder cancer therapy wins NICE backing
